로고
About us
Company overview
History
Leadership
Business Strategy
Contact us
Platform Technology
IMBolution Technology
ePENDY Technology
Pipeline
IMB-101
IMB-102
IMB-201
IMB-202
IMB-401/IMB-402
Media Room
Notice
News
Gallery
Careers
Culture
Recruiting Information
언어선택
ENG
KOR
ENG
전체메뉴
About us
Company overview
History
Leadership
Business Strategy
Contact us
Platform Technology
IMBolution Technology
ePENDY Technology
Pipeline
IMB-101
IMB-102
IMB-201
IMB-202
IMB-401/IMB-402
Media Room
Notice
News
Gallery
Careers
Culture
Recruiting Information
Gallery
Innovative Medicines based on
ImmunoModulatory Biologics
Media Room
About us
Platform Technology
Pipeline
Media Room
Careers
Gallery
Notice
News
Gallery
Total
5
IMBiologics, License Agreement with Huadong Medicine
2024-08-27
IMBiologics &, Navigator Medicines
2024-06-27
IMBiologics, License Agreement with Navigator Medicines
2024-06-27
IMBiologics, MOU with Canton Biologics
2023-10-31
IMBiologics
2022-04-06
Total
전체
제목
내용
President(CEO) : Gyongsik Ha
260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea